We are developing medical products that will revolutionize the process of post-operative cancerous tissue assessment.
Kulira Technologies is developing a proprietary disposable tissue-stabilizing gel that will revolutionize the process of post-operative tissue assessment in surgical pathology in the $7.6 B veterinary and oncology markets.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free